Cardinal Health Inc. [NYSE: CAH] closed the trading session at $60.01 on 06/10/21. The day’s price range saw the stock hit a low of $58.54, while the highest price level was $60.16. The company report on June 10, 2021 that Cardinal Health™ Nuclear & Precision Health Solutions Receives U.S. Food and Drug Administration Approval for New LYMPHOSEEK® Pediatric Indication.
The new indication will provide accurate and precise lymph node identification in pediatric patients one month and older with melanoma, rhabdomyosarcoma or other types of solid tumors.
Cardinal Health (NYSE: CAH) announced that LYMPHOSEEK® (technetium Tc 99m tilmanocept) injection – the first and only radiopharmaceutical agent specifically designed for targeted lymphatic mapping and guiding sentinel lymph node biopsies (SLNB) – has been approved for pediatric use by the U.S. Food and Drug Administration (FDA).
The stocks have a year to date performance of 12.04 percent and weekly performance of 6.50 percent. The stock has been moved at 6.27 percent over the last six months. The stock has performed 6.84 percent around the most recent 30 days and changed 7.70 percent over the most recent 3-months.
If compared to the average trading volume of 2.09M shares, CAH reached to a volume of 2857862 in the most recent trading day, which is why market watchdogs consider the stock to be active.
Here’s what leading stock market gurus have to say about Cardinal Health Inc. [CAH]:
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for CAH shares is $63.06 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on CAH stock is a recommendation set at 2.60. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
Robert W. Baird have made an estimate for Cardinal Health Inc. shares, keeping their opinion on the stock as Neutral, with their previous recommendation back on May 10, 2021. The new note on the price target was released on January 08, 2021, representing the official price target for Cardinal Health Inc. stock. Previously, the target price had yet another raise to $57, while Barclays analysts kept a Overweight rating on CAH stock.
The Average True Range (ATR) for Cardinal Health Inc. is set at 1.40, with the Price to Sales ratio for CAH stock in the period of the last 12 months amounting to 0.11. The Price to Book ratio for the last quarter was 9.79, with the Price to Cash per share for the same quarter was set at 12.10. Price to Free Cash Flow for CAH in the course of the last twelve months was 18.55 with Quick ratio for the last quarter at 0.60.
CAH stock trade performance evaluation
Cardinal Health Inc. [CAH] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 6.50. With this latest performance, CAH shares gained by 6.84% in over the last four-week period, additionally plugging by 6.27% over the last 6 months – not to mention a rise of 8.18% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for CAH stock in for the last two-week period is set at 63.25, with the RSI for the last a single of trading hit 72.28, and the three-weeks RSI is set at 58.53 for Cardinal Health Inc. [CAH]. The present Moving Average for the last 50 days of trading for this stock 58.80, while it was recorded at 58.57 for the last single week of trading, and 54.13 for the last 200 days.
Cardinal Health Inc. [CAH]: An insightful look at the core fundamentals
Operating Margin for any stock indicates how profitable investing would be, and Cardinal Health Inc. [CAH] shares currently have an operating margin of +1.16 and a Gross Margin at +4.15. Cardinal Health Inc.’s Net Margin is presently recorded at -2.42.
Return on Total Capital for CAH is now 15.24, given the latest momentum, and Return on Invested Capital for the company is -32.42. Return on Equity for this stock declined to -91.07, with Return on Assets sitting at -9.04. When it comes to the capital structure of this company, Cardinal Health Inc. [CAH] has a Total Debt to Total Equity ratio set at 403.58. Additionally, CAH Total Debt to Total Capital is recorded at 80.14, with Total Debt to Total Assets ending up at 17.71. Long-Term Debt to Equity for the company is recorded at 397.21, with the Long-Term Debt to Total Capital now at 78.88.
Reflecting on the efficiency of the workforce at the company, Cardinal Health Inc. [CAH] managed to generate an average of -$77,000 per employee. Receivables Turnover for the company is 18.27 with a Total Asset Turnover recorded at a value of 3.74.Cardinal Health Inc.’s liquidity data is similarly interesting compelling, with a Quick Ratio of 0.60 and a Current Ratio set at 1.20.
Earnings per share (EPS) analysis for Cardinal Health Inc. [CAH] stock
With the latest financial reports released by the company, Cardinal Health Inc. posted 1.04/share EPS, while the average EPS was predicted by analysts to be reported at 0.92/share. When compared, the two values demonstrate that the company surpassed the estimates by a Surprise Factor of 13.00%. The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for CAH. When it comes to the mentioned value, analysts are expecting to see the 5-year EPS growth rate for Cardinal Health Inc. go to 6.83%.
Cardinal Health Inc. [CAH]: Insider Ownership positions
There are presently around $14,710 million, or 87.30% of CAH stock, in the hands of institutional investors. The top three institutional holders of CAH stocks are: VANGUARD GROUP INC with ownership of 36,108,628, which is approximately 1.115% of the company’s market cap and around 0.17% of the total institutional ownership; BLACKROCK INC., holding 27,394,980 shares of the stock with an approximate value of $1.64 billion in CAH stocks shares; and STATE STREET CORP, currently with $1.05 billion in CAH stock with ownership of nearly -3.889% of the company’s market capitalization.
Positions in Cardinal Health Inc. stocks held by institutional investors increased at the end of May and at the time of the May reporting period, where 395 institutional holders increased their position in Cardinal Health Inc. [NYSE:CAH] by around 16,088,876 shares. Additionally, 361 investors decreased positions by around 18,357,697 shares, while 124 investors held positions by with 210,682,869 shares. The mentioned changes placed institutional holdings at 245,129,442 shares, according to the latest SEC report filing. CAH stock had 99 new institutional investments in for a total of 2,063,448 shares, while 77 institutional investors sold positions of 2,216,917 shares during the same period.